Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotype and molecular characterization of the first inhibitor-resistant TEM-derived beta-lactamase identified in Portugal.

Antimicrobial agents and chemotherapy - 1 Nov 2002

Caniça Manuela, Ferreira Mónica, Ferreira Eugénia, Cabral Luísa

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to beta-Lactamase Inhibitors
Share to beta-Lactamases
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Inhibitors

Share to Escherichia coli Infections

Share to Portugal

Share to Reverse Transcriptase Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 12384395
DOI: 10.1128/AAC.46.11.3688-3689.2002
PMCID: PMC128722

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotype and molecular characterization of the first inhibitor-resistant TEM-derived beta-lactamase identified in Portugal.PMID 12384395Read ↗

β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited ResourcesSemantic proximity Read ↗

Extended-spectrum beta-lactamases: the role of inhibitors in therapy.Semantic proximity Read ↗

Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.Semantic proximity Read ↗

Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance.Semantic proximity Read ↗

&#946;-Lactamases: A Survey of Protein DiversitySemantic proximity Read ↗

Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants.Semantic proximity Read ↗

Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase InhibitorsSemantic proximity Read ↗

[Broad-spectrum beta-lactamases. Clinical significance and detection methods].Semantic proximity Read ↗

Unveiling the evolution routes of TEM-type extended-spectrum β-lactamases.Semantic proximity Read ↗

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical UseSemantic proximity Read ↗

Evolving trends of New Delhi Metallo-betalactamse (NDM) variants: A threat to antimicrobial resistance.Semantic proximity Read ↗

beta-Lactamases in laboratory and clinical resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.